Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (7275)	9/23/1998 6:00:00 AM
From: Robert K.	Respond to of 17367

Mike -here is a "general outline of reasons to use bpi" >as anti-endotoxin >as antibacterial >as antifungal >as antiangiogenic >as antiinflamatory Now you are looking to anti-angiogenic. Thats fine. That is IMO one of the most promising lines of cancer research of which entremed has popularized. You have 4 (main)points to consider. 1. bpi21 is antiangiogenic 2 I-prex is antiangiogenic 3. the overall competition and the stage everyone is at 4. how antiangio fits in with the other opportunities available to X All IMO. Consider nothing as fact.